These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34921596)

  • 81. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
    Mercuri E; Darras BT; Chiriboga CA; Day JW; Campbell C; Connolly AM; Iannaccone ST; Kirschner J; Kuntz NL; Saito K; Shieh PB; Tulinius M; Mazzone ES; Montes J; Bishop KM; Yang Q; Foster R; Gheuens S; Bennett CF; Farwell W; Schneider E; De Vivo DC; Finkel RS;
    N Engl J Med; 2018 Feb; 378(7):625-635. PubMed ID: 29443664
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Needleless inhaled anesthesia with sevoflurane: Advantages of a simplified approach for children with spinal muscular atrophy undergoing intrathecal administration of nusinersen.
    Salerno A; Picconi E; Genovese O; Piastra M; Pulitanò SM; Tosi F; Mancino A; Pane M; De Sanctis R; Carlini D; Mercuri EM; Conti G
    Paediatr Anaesth; 2023 Apr; 33(4):282-290. PubMed ID: 36636888
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Ultrasound-guided interlaminar approach for nusinersen administration in patients with spinal muscular atrophy with spinal fusion or severe scoliosis.
    Wei C; Liang Z; Wu Y; Liu S; Qiu J; Meng L; Li C; Li S; Bao X; Wang Z; Chen L; Xiong H
    Orphanet J Rare Dis; 2023 Feb; 18(1):30. PubMed ID: 36800969
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Sleep and Breathing After Nusinersen Therapy in a Child With Spinal Muscular Atrophy.
    Kouri I; Demirel N; Haile DT; Selcen D; Kotagal S
    J Clin Neuromuscul Dis; 2020 Dec; 22(2):105-108. PubMed ID: 33214397
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nusinersen does not improve lung function in a cohort of children with spinal muscular atrophy - A single-center retrospective study.
    Heitschmidt L; Pichlmaier L; Eckerland M; Steindor M; Olivier M; Fuge I; Kölbel H; Hirtz R; Stehling F
    Eur J Paediatr Neurol; 2021 Mar; 31():88-91. PubMed ID: 33711791
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen.
    Bonanno S; Zanin R; Bello L; Tramacere I; Bozzoni V; Caumo L; Ferraro M; Bortolani S; Sorarù G; Silvestrini M; Vacchiano V; Turri M; Tanel R; Liguori R; Coccia M; Mantegazza RE; Mongini T; Pegoraro E; Maggi L
    J Neurol; 2022 Jun; 269(6):3264-3275. PubMed ID: 34978620
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nusinersen treatment in a type 3 spinal muscular atrophy patient during early pregnancy.
    Schön M; Domingues S; de Carvalho M; Oliveira Santos M
    Neurol Sci; 2023 May; 44(5):1803-1804. PubMed ID: 36645532
    [No Abstract]   [Full Text] [Related]  

  • 88. Resolution of skin necrosis after nusinersen treatment in an infant with spinal muscular atrophy.
    Salmin F; Albamonte E; Morettini V; Gagliano N; Mercuri E; Sansone VA
    Muscle Nerve; 2019 Jun; 59(6):E42-E44. PubMed ID: 30811610
    [No Abstract]   [Full Text] [Related]  

  • 89. Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1.
    Fitzgerald DA; Doumit M; Abel F
    Paediatr Respir Rev; 2018 Sep; 28():11-17. PubMed ID: 30414815
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nusinersen treatment of older children and adults with spinal muscular atrophy.
    Konersman CG; Ewing E; Yaszay B; Naheedy J; Murphy S; Skalsky A
    Neuromuscul Disord; 2021 Mar; 31(3):183-193. PubMed ID: 33608138
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Nusinersen for SMA: expanded access programme.
    Farrar MA; Teoh HL; Carey KA; Cairns A; Forbes R; Herbert K; Holland S; Jones KJ; Menezes MP; Morrison M; Munro K; Villano D; Webster R; Woodcock IR; Yiu EM; Sampaio H; Ryan MM
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):937-942. PubMed ID: 29549190
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis.
    Coratti G; Cutrona C; Pera MC; Bovis F; Ponzano M; Chieppa F; Antonaci L; Sansone V; Finkel R; Pane M; Mercuri E
    Orphanet J Rare Dis; 2021 Oct; 16(1):430. PubMed ID: 34645478
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy.
    Osmanovic A; Ranxha G; Kumpe M; Müschen L; Binz C; Wiehler F; Paracka L; Körner S; Kollewe K; Petri S; Schreiber-Katz O
    J Neurol; 2020 Aug; 267(8):2398-2407. PubMed ID: 32361837
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Administration of nusinersen via paramedian approach for spinal muscular atrophy.
    Iwayama H; Wakao N; Kurahashi H; Kubota N; Hattori A; Kumagai T; Okumura A
    Brain Dev; 2021 Jan; 43(1):121-126. PubMed ID: 32773161
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel use of nusinersen as a therapeutic bridge to onasemnogene abeparvovec-xioi in a premature neonate with type 1 spinal muscular atrophy.
    Ferrante L; Melendez-Zaidi A; Lindsey W; Lotze T
    Muscle Nerve; 2022 Aug; 66(2):E8-E10. PubMed ID: 35616550
    [No Abstract]   [Full Text] [Related]  

  • 96. Nusinersen: A Review in 5q Spinal Muscular Atrophy.
    Hoy SM
    CNS Drugs; 2021 Dec; 35(12):1317-1328. PubMed ID: 34850360
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
    Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
    Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evolving Surgical Management for Early-Onset Scoliosis in Spinal Muscular Atrophy Type 1 Given Improvements in Survival.
    Drain JP; Iobst CA; Chambers R; Seilhamer C; Beebe AC; Klamar JE
    JBJS Case Connect; 2021 Mar; 11(1):. PubMed ID: 33755639
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Natural History of Type 1 Spinal Muscular Atrophy in a Series of Argentinian Children.
    Aguerre V; De Castro F; Mozzoni J; Gravina LP; Araoz HV; Monges S
    J Neuromuscul Dis; 2020; 7(4):453-458. PubMed ID: 32925085
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Complex Spine in Children with Spinal Muscular Atrophy: The Transforaminal Approach-A Transformative Technique.
    Towbin R; Schaefer C; Kaye R; Abruzzo T; Aria DJ
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1422-1426. PubMed ID: 31296522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.